LAG3-MHCII interaction induces a tight cell-cell interface at the immunological synapse
The Journal of Immunology · 2025
DOI: 10.1093/jimmun/vkaf120 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, 2025. Verfasst von Zibin Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Pharmaceutical Biotechnology, MOE Engineering Research Center of Protein and Peptide Medicine, School of Life Sciences, Chemi…. Hauptthemen laut MEDLINE: Immunological Synapses, Histocompatibility Antigens Class II, Antigens, CD, T-Lymphocytes. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Major Projects of Jiangsu Province.
Abstract (Originalsprache)
Lymphocyte activation gene 3 (LAG3), an immune checkpoint, inhibits T cell function by binding to major histocompatibility complex class II (MHCII). Although LAG3 holds significant therapeutic potential for cancer immunotherapy, the molecular mechanisms underlying LAG3-mediated immunosuppression remain poorly characterized. Here, using a reconstituted cell conjugation assay, we demonstrate that LAG3 binds directly to MHCII in a T cell receptor signaling–independent manner. Beyond its role in modulating intercellular adhesion, the LAG3-MHCII interaction remodels the architecture of the immunological synapse (IS). Correlative light and electron microscopy reveals that the LAG3-MHCII interaction creates a remarkably tight cell-cell interface at the IS, which selectively excludes CD4, large receptor-ligand complexes, and whole IgG of LAG3 antibodies. Conversely, the Fab fragment of LAG3 antibodies can penetrate this tight interface, block LAG3-MHCII binding, and enhance T cell responses. In addition, the LAG3-MHCII interaction directly facilitates MHCII trogocytosis. These findings demonstrate that the LAG3-MHCII interaction establishes a selective physical barrier at the IS, providing novel mechanistic insights into LAG3-mediated immunosuppression and suggesting feasible strategies for the development of more effective immunotherapeutic drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Pharmaceutical Biotechnology, MOE Engineering Research Center of Protein and Peptide Medicine, School of Life Sciences, Chemistry and Biomedicine Innovation Center, Nanjing University, Nanjing, C…
- Analysis and Test Center, Nanjing Medical University, Nanjing, China.
- Department of Oncology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
- National Resource Center for Mutant Mice, MOE Key Laboratory of Model Animals for Disease Study, MOE Engineering Research Center of Protein and Peptide Medicine, Chemistry and Biomedicine Innovation Center, Model Animal…
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Major Projects of Jiangsu Province
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Wang, Z., Zhou, T., Wang, H., Li, H., Zhao, W., Wang, F., Li, Y., Liu, W., Wei, J., & Dong, X. (2025). LAG3-MHCII interaction induces a tight cell-cell interface at the immunological synapse. The Journal of Immunology. https://doi.org/10.1093/jimmun/vkaf120
Vancouver
Wang Z, Zhou T, Wang H, Li H, Zhao W, Wang F, et al. LAG3-MHCII interaction induces a tight cell-cell interface at the immunological synapse. The Journal of Immunology. 2025. doi:10.1093/jimmun/vkaf120
BibTeX
@article{Wang2025,
author = {Wang, Zibin and Zhou, Ting and Wang, Hanbing and Li, He and Zhao, Wene and Wang, Feng and Li, Yan and Liu, Wen and Wei, Jia and Dong, Xianchi},
title = {LAG3-MHCII interaction induces a tight cell-cell interface at the immunological synapse},
journal = {The Journal of Immunology},
year = {2025},
doi = {10.1093/jimmun/vkaf120}
}
EUVIMED